Page last updated: 2024-08-16

delavirdine and erythromycin

delavirdine has been researched along with erythromycin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	3 (50.00)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dansette, PM; Fontana, E; Poli, SM	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Amidon, GL; Blake, DS; Carver, PL; Cheng, CL; Cox, SR; Kauffman, CA; Meyer, KM; Smith, DE; Stetson, PL; Watkins, PB	1
Wagner, D	1

Reviews

2 review(s) available for delavirdine and erythromycin

Article	Year
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Current drug metabolism, 2005, Volume: 6, Issue:5 Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic	2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for delavirdine and erythromycin

Article	Year
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clinical pharmacology and therapeutics, 1997, Volume: 61, Issue:5 Topics: Administration, Oral; Adult; Alkylation; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Delavirdine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Erythromycin; HIV Seropositivity; Humans; Indoles; Liver; Male; Oxidoreductases, N-Demethylating; Piperazines; Protein Binding; Protein Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Substrate Specificity	1997

Article

Year

Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test.

Clinical pharmacology and therapeutics, 1997, Volume: 61, Issue:5

Topics: Administration, Oral; Adult; Alkylation; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Delavirdine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Erythromycin; HIV Seropositivity; Humans; Indoles; Liver; Male; Oxidoreductases, N-Demethylating; Piperazines; Protein Binding; Protein Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Substrate Specificity

1997

Other Studies

3 other study(ies) available for delavirdine and erythromycin

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
CYP3A4 and the erythromycin breath test. Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:1 Topics: Anti-Bacterial Agents; Anti-HIV Agents; Breath Tests; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delavirdine; Erythromycin; Humans; Mixed Function Oxygenases	1998